Prenetics Global Limited (PRE) closed at $0.85 in the latest trading session, marking a +0.01% move from the prior day.
Based on the average brokerage recommendation (ABR), Prenetics Global Limited (PRE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness...
Prenetics Global Limited (PRE) closed at $0.83 in the latest trading session, marking a -0.59% move from the prior day.
We have narrowed our search to four U.S.-based medical stocks with attractive valuations. These are HROW, LSTA, OCUP and PRE.
Prenetics Global Limited (PRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings...
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
The company announced a key FDA clearance.
HONG KONG, Dec 16, 2022 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, is acquiring a majority stake of ACT,...
LONDON AND HONG KONG, Nov 30, 2022 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its...
LONDON AND HONG KONG, Nov 10, 2022 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited...